| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef416fe4f66ebb1021cecfb0ba5ae45d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d53e55c12ffa42dea854d90ecccb39b9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 |
| filingDate |
2002-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10a357f27a2a3276083fa0ffee5b867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00148ecfc4d416ad6d421b9260b7ddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c515c80d2b3ea302b2027091a3d172 |
| publicationDate |
2004-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1463522-A1 |
| titleOfInvention |
Human antipneumococcal antibodies from non-human animals |
| abstract |
The present invention relates to human antibodies produced in non-human animals which specifically bind to the capsular polysaccharide (PPS-3) of <i> Streptococcus pneumoniae </i>. The invention also relates to methods of making the above antibodies in a non-human animal and expressing the antibodies in cells comprising hybridomas and recombinant host cell systems. The invention further relates to kits and pharmaceutical compositions comprising the antibodies of the invention, as well as methods of treating, inhibiting or preventing infection with <i> S. pneumoniae </i> or the conditions or disorders caused by this infection by administering to the patient the abovementioned pharmaceutical compositions. |
| priorityDate |
2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |